ask="2.10"
ask_size="8000"
average_daily_volume="1587630"
bid="1.95"
bid_size="500"
book_value="1.98"
change="+0.71"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="0.11"
change_from_52_week_high="-5.85"
change_From_52_week_low="0.96"
change_in_percent="+53.38%"
close="2.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.08"
ex_dividend_date="N/A"
float_shares="10213000"
high="2.76"
high_52_weeks="7.89"
last_trade_date="3/10/2017"
last_trade_price="2.04"
last_trade_size="10695"
last_trade_time="4:00pm"
low="1.58"
low_52_weeks="1.08"
market_capitalization="38.05M"
moving_average_200_day="3.67"
moving_average_50_day="1.93"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.90"
open="1.69"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-44.35%"
percent_change_from_50_day_moving_average="+5.59%"
percent_change_from_52_week_high="-74.14%"
percent_change_from_52_week_low="+88.89%"
previous_close="1.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.67"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="0.51"
stock_exchange="NGM"
symbol="CATB"
volume="59565706"
weeks_range_52="1.08 - 7.89"
